The feasibility and safety of early discharge for low risk patients with acute myocardial infarction after successful direct percutaneous coronary intervention

被引:12
|
作者
Yip, HK
Wu, CJ
Chang, HW
Hang, CL
Wang, CP
Yang, CH
Hung, WC
Yu, TH
Yeh, KH
Chua, S
Fu, M
Chen, MC
机构
[1] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Kaohsiung 83301, Taiwan
[2] Natl Sun Yat Sen Univ, Dept Sci Biol, Kaohsiung 80424, Taiwan
来源
JAPANESE HEART JOURNAL | 2003年 / 44卷 / 01期
关键词
acute myocardial infarction; direct percutaneous coronary intervention; early discharge; low risk patients;
D O I
10.1536/jhj.44.41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a lack of consensus among cardiologists regarding the length of time patients should be hospitalized after an uncomplicated acute myocardial infarction (AMI) and successful direct percutaneous coronary intervention (d-PCI). The purpose of this study was to evaluate the feasibility and safety of early discharge (discharge <4 days after the procedure) for low risk patients with AMI who underwent successful d-PCI. From May 1996 through December 2001, d-PCI was performed in 898 consecutive patients with AMI Of these 898 patients, 463 (51.6%) were stratified to be at low risk. Lower risk was defined as: (1) Killip classification less than or equal to2 on admission; (2) the infarct-related artery achieved normal blood flow without recurrent ischemia or reinfarction in the first 24 hours; (3) no mechanical or electrical complications after d-PCI, (4) no acute renal failure, acute stroke, or major bleeding cornplication; (5) no advanced congestive heart failure (defined asgreater than or equal toNew York Heart Association functional class 3); and (6) no sepsis. Patients who were discharged <4 days after undergoing the procedure were enrolled in group 1 (n=266). Patients who were discharged >= 4 days after undergoing the procedure were enrolled in group 2 (n=197). Univariate analysis demonstrated that group 2 patients had a significantly longer hospital stay (P=0.0001) than group I patients. At the first 30-day follow-up examination, there were no significant differences in the combined major cardiac events (death, recurrent ischemia, reinfarction, revascularization, or advanced congestive heart failure) between the group I and group 2 patients (1.50% vs 1.52%, P=0.92). There were also no significant differences in the combined major noncardiac complications (acute stroke, acute renal failure, bleeding complications requiring blood transfusion, vascular sequelae, or sepsis) between the group I and group 2 patients (1.13% vs 0.51%, P=0.89). Early discharge was feasible in a majority of the patients who experienced AMI and were at lower risk 24 hours after successful d-PCI. Thus, the patients had a shortened hospital stay and no increased risk.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [21] Clinical and procedural predictors of no-ref low in patients with acute myocardial infarction after primary percutaneous coronary intervention
    Hua Zhou
    Xiao-yan He
    Shao-wei Zhuang
    Juan Wang
    Yan Lai
    Wei-gang Qi
    Yi-an Yao
    Xue-bo Liu
    World Journal of Emergency Medicine, 2014, (02) : 96 - 102
  • [22] Safety and Feasibility of Same Day Discharge Strategy for Primary Percutaneous Coronary Intervention
    Shah, Jehangir Ali
    Saghir, Tahir
    Ahmed, Bashir
    ul Haq, Syed Alishan
    Kumar, Rajesh
    Mengal, Muhammad Naeem
    Zehra, Mehwish
    Raza, Syeda Sakeena
    Karim, Musa
    Qamar, Nadeem
    GLOBAL HEART, 2021, 16 (01)
  • [23] Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome
    Higuchi, Satoshi
    Kabeya, Yusuke
    Nishina, Yoshio
    Miura, Yusuke
    Yoshino, Hideaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (07) : E666 - E673
  • [24] Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
    Feng, Chunguang
    Liu, Yi
    Wang, Lulu
    Niu, Dongdong
    Han, Bing
    HEART LUNG AND CIRCULATION, 2019, 28 (06) : 858 - 865
  • [25] Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention
    Liang, Jing
    Wang, Zhijian
    Zhou, Yujie
    Shen, Hua
    Chai, Meng
    Ma, Xiaoteng
    Han, Hongya
    Shao, Qiaoyu
    Li, Qiuxuan
    CURRENT VASCULAR PHARMACOLOGY, 2022, 20 (06) : 517 - 526
  • [26] Feasibility of early hospital discharge directly from coronary care unit after primary angioplasty for uncomplicated acute myocardial infarction
    Pernat, Andrej
    Lainscak, Mitja
    Mohar, Aleksandra
    Noc, Marko
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2009, 4 (02): : 212 - 217
  • [27] Prognostic value of cardiopulmonary exercise test in patients with acute myocardial infarction after percutaneous coronary intervention
    Li, Zhengyan
    Fan, Baochao
    Wu, Yifan
    Rui, Haomiao
    Hu, Yongcun
    Gu, Yingchun
    Bai, Juncai
    Lu, Liming
    Wang, Dongwei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention
    Tsai, Tzu-Hsien
    Chua, Sarah
    Hussein, Hisham
    Leu, Steve
    Wu, Chiung-Jen
    Hang, Chi-Ling
    Fang, Hsiu-Yu
    Chung, Sheng-Ying
    Fu, Morgan
    Chen, Huang-Chung
    Chang, Li-Teh
    Yeh, Kuo-Ho
    Yip, Hon-Kan
    CRITICAL CARE MEDICINE, 2011, 39 (03) : 436 - 442
  • [29] Effects of renal denervation on cardiac function after percutaneous coronary intervention in patients with acute myocardial infarction
    Gao, Jun-Qing
    Xu, You-Long
    Ye, Jian
    Hou, Shu-Xin
    Yang, Wei
    Li, Min
    Fa, Jing-Jing
    Yang, Cheng-Hao
    Jin, Hui -Gen
    He, Rui-Qing
    Liu, Zong-Jun
    HELIYON, 2023, 9 (07)
  • [30] Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris
    Solheim, S.
    Grogaard, H. K.
    Hoffmann, P.
    Arnesen, H.
    Seljeflot, Ingebjorg
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (07) : 555 - 562